Approval · Notice of Compliance 19546 · 2017
ABELCET: Notice of Compliance 19546
Issued July 20, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19546
- Date
- July 20, 2017
- Company
- Leadiant Biosciences, Inc.Scarborough, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ABELCET | 02231590 | Cancelled Post Market |
Medicinal ingredients
- AMPHOTERICIN B 5 MG per ML